INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE
Midterm performance of a novel restorative pulmonary valved conduit: preclinical results
EuroIntervention 2017;13:e1418-e1427 published online August 2017 published online e-edition December 2017. DOI: 10.4244/EIJ-D-17-00553
Osama I. Soliman1,2*, MD, PhD; Yosuke Miyazaki1, MD, PhD; Mohammad Abdelghani3, MD; Marieke Brugmans4, PhD; Maarten Witsenburg5, MD, PhD; Yoshinobu Onuma1,2, MD, PhD; Martijn Cox4, PhD; Patrick W. Serruys6, MD, PhD
1. Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands; 2. Cardialysis, Rotterdam, the Netherlands; 3. Department of Cardiology, Academic Medical Center Amsterdam, Amsterdam, the Netherlands; 4. Xeltis BV,
Aims: The Xeltis bioabsorbable pulmonary valved conduit (XPV), designed to guide functional restoration of patients’ own tissue, is potentially more durable than current pulmonary bi